跳至主要内容
临床试验/NCT02122055
NCT02122055Unknown4 期

Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU, A Randomized Controlled Study.

Tianjin Third Central Hospital0 个研究点目标入组 100 人开始时间: 2014年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
100
主要终点
Ventilation duration

研究概览

简要总结

For the patient who passed the screen of weaning from ventilation, the traditional sedation drug such as propofol and midazolam should be decreased or stopped, then it would induce the stress response and agitation, such as hypertension,tachycardia etc. In order to resolve that problem, the sedation should be given again. but if renewed to sedation, it would cause prolonged sedation and ventilation duration.

So as to resolve above issues, after the patient passed the screen of weaning, sedation is changed to Dexmedetomidine, a new sedation drug, that could wake up at any time. So our study to compare the efficacy and safety of sequential sedation of propofol or midazolam and dexmedetomidine in mechanical ventilated ICU patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written Informed Consent
  • Anticipated Ventilation and sedation duration of at least 48 hours
  • Age≥18 years old
  • Weight is in the range of ±20% of standard weight.[Standard weight= (Height(cm)-80)×70﹪ for male and (Height(cm)-70)×60﹪for female] -

排除标准

  • Extremely unstable of circulatory system, such as systolic blood pressure less than 90 mm Hg despite continuous infusions of vasopressors before the start of study drug infusion or shock;
  • Heart rate less than 50 bpm
  • Second or third degree heart block
  • Serious central nervous system pathology(acute stroke, uncontrolled seizures,severe dementia)
  • Acute hepatitis or severe liver disease (Child-Pugh class C)
  • Dialysis of all types 7)History of neuromuscular disease
  • Unstable mental status and metal illness 9) Sure or suspected abuse of narcotics and alcohol independence 10) Allergy to experimental drug and other contraindication 11) Advanced tumor patients 12) Neuromuscular blockade other than for intubation 13) Pregnancy or lactation 14) Patient that participate other trial at past 30 days -

研究组 & 干预措施

Propofol/Dexmedetomidine

Experimental
  1. Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Fentanyl (Drug)

Propofol/Dexmedetomidine

Experimental
  1. Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Sedation assessment (Procedure)

Propofol/Dexmedetomidine

Experimental
  1. Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Screen of weaning (Procedure)

Propofol/Dexmedetomidine

Experimental
  1. Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Propofol (Drug)

Propofol/Dexmedetomidine

Experimental
  1. Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Dexmedetomidine (Drug)

Midazolam/Dexmedetomidine

Experimental
  1. Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Fentanyl (Drug)

Midazolam/Dexmedetomidine

Experimental
  1. Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Sedation assessment (Procedure)

Midazolam/Dexmedetomidine

Experimental
  1. Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Screen of weaning (Procedure)

Midazolam/Dexmedetomidine

Experimental
  1. Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Midazolam (Drug)

Midazolam/Dexmedetomidine

Experimental
  1. Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.
  2. After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Ventilation duration

时间窗: From intubation to weaning from mechanical ventilation, up to 7 days.

The time of intubation and the time of weaning from mechanical ventilation are recorded.

次要结局

  • Delirium(From the beginning of sedation to discharge from ICU, up to 28 days.)
  • Blood pressure(From the beginning to weaning of sedation, up to 7 days.)
  • Cost of sedation drug(From the admition to discharge from ICU,up to 28 days.)
  • Cost of narcotics(From the admition to discharge from ICU,up to 28 days.)
  • Cost of ICU stay(From the beginning to weaning of sedation, up to 7 days.)
  • Heart rate(From the beginning to weaning of sedation, up to 7 days.)
  • Respiration Rate(From the beginning to weaning of sedation, up to 7 days.)
  • Pulse blood oxygen saturation(From the beginning to weaning of sedation, up to 7 days.)

研究者

申办方类型
Other
责任方
Sponsor

相似试验